Sargent Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
22,998
+3,260
| +17% | +$146K | 0.14% | 99 |
|
|
2025
Q1 | $1.2M | Buy |
19,738
+2,082
| +12% | +$127K | 0.19% | 83 |
|
|
2024
Q4 | $977K | Buy |
17,656
+8,387
| +90% | +$464K | 0.16% | 97 |
|
|
2024
Q3 | $480K | Buy |
+9,269
| New | +$480K | 0.09% | 122 |
|
|
2024
Q1 | – | Sell |
-5,741
| Closed | -$295K | – | 206 |
|
|
2023
Q4 | $295K | Sell |
5,741
-4,025
| -41% | -$207K | 0.06% | 166 |
|
|
2023
Q3 | $567K | Buy |
9,766
+521
| +6% | +$30.2K | 0.14% | 109 |
|
|
2023
Q2 | $591K | Sell |
9,245
-157
| -2% | -$10K | 0.14% | 108 |
|
|
2023
Q1 | $655K | Buy |
9,402
+75
| +0.8% | +$5.23K | 0.17% | 98 |
|
|
2022
Q4 | $671K | Hold |
9,327
| – | – | 0.21% | 92 |
|
|
2022
Q3 | $655K | Sell |
9,327
-446
| -5% | -$31.3K | 0.2% | 90 |
|
|
2022
Q2 | $753K | Sell |
9,773
-930
| -9% | -$71.7K | 0.23% | 81 |
|
|
2022
Q1 | $782K | Buy |
10,703
+116
| +1% | +$8.48K | 0.2% | 91 |
|
|
2021
Q4 | $660K | Sell |
10,587
-360
| -3% | -$22.4K | 0.15% | 102 |
|
|
2021
Q3 | $648K | Buy |
10,947
+335
| +3% | +$19.8K | 0.16% | 102 |
|
|
2021
Q2 | $709K | Buy |
10,612
+15
| +0.1% | +$1K | 0.17% | 98 |
|
|
2021
Q1 | $669K | Buy |
10,597
+2,017
| +24% | +$127K | 0.18% | 99 |
|
|
2020
Q4 | $532K | Buy |
8,580
+4,395
| +105% | +$273K | 0.17% | 99 |
|
|
2020
Q3 | $252K | Buy |
+4,185
| New | +$252K | 0.09% | 141 |
|